Healthcare / Medical - Equipment & ServicesUpdated 2026-05-10 22:07 UTC

LON/0R2S stock hub

LON/0R2S has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0R2Sis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

80.2B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0R2S

In the news

Latest news · LON/0R2S

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E18

P25 12.9P50 16.9P75 23.5

Trailing P/E31.7

P25 15.9P50 22.9P75 35.8

ROE15.2

P25 -54.2P50 2.1P75 13.7

ROIC12

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0R2S market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

230

Groups with data

Currency

USD

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	56,000
Employees Change	3,000%
Employees Change Percent	5.66
Enterprise value	$88.5B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Equipment & Services
Isin	US8636671013
Last refreshed	2026-05-10
Market cap	$80.2B
Price	$289
Price currency	USD
Rev Per Employee	341,733.88x
Sector	Healthcare
Sic	3841
Symbol	lon/0R2S
Website	https://www.stryker.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.15%
EV Earnings	35.02x
EV/EBIT	21.17x
EV/EBITDA	17.43x
EV/FCF	25.57x
EV/Sales	4.77x
FCF yield	4.31%
Forward P/E	17.99x
P/B ratio	4.61x
P/E ratio	31.75x
P/S ratio	4.19x
PE Ratio10 Y	40.38x
PE Ratio3 Y	42.48x
PE Ratio5 Y	42.88x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	22.54%
EBITDA Margin	27.38%
FCF margin	18.09%
Gross margin	64.7%
Gross Profit	$12.4B
Gross Profit Growth	8.83%
Gross Profit Growth Q	0.34%
Gross Profit Growth3 Y	11.1%
Gross Profit Growth5 Y	11.7%
Net Income	$2.5B
Net Income Growth	16.72%
Net Income Growth Q	13.91%
Net Income Growth Quarters	4%
Net Income Growth Years	1%
Net Income Growth3 Y	8.3%
Net Income Growth5 Y	18.84%
Pretax Margin	18.2%
Profit Margin	13.21%
Profit Per Employee	$45,127
Profitable Years	14
ROA	7.72
Roa5y	6.99
ROCE	14.25
ROE	15.2
Roe5y	15.51
ROIC	11.99
Roic5y	12.85

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-23.47%
Cagr3y	1.51%
Cagr5y	3.81%
Div CAGR3	1.7%
Div CAGR5	6.83%
EPS Growth	16.76
EPS Growth Q	14.2
EPS Growth Quarters	4
EPS Growth Years	1
EPS Growth3 Y	7.94
EPS Growth5 Y	18.55
FCF Growth	27.79%
FCF Growth Q	226.77%
FCF Growth3 Y	26.33%
FCF Growth5 Y	11.01%
OCF Growth	25.35%
OCF Growth Q	132.4%
OCF Growth10 Y	21.28%
OCF Growth3 Y	23.32%
OCF Growth5 Y	11.36%
Revenue Growth	8.84x
Revenue Growth Q	2.63x
Revenue Growth Quarters	23x
Revenue Growth Years	5x
Revenue Growth3 Y	10.07x
Revenue Growth5 Y	11.42x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.55
Assets	$35.1B
Cash	$2.2B
Current Assets	$9.8B
Current Liabilities	$4.6B
Debt	$10.8B
Debt EBITDA	$2.06
Debt Equity	$0.62
Debt FCF	$3.11
Equity	$17.4B
Interest Coverage	9.39
Liabilities	$17.7B
Long Term Assets	$25.3B
Long Term Liabilities	$13B
Net Cash	$-8.5B
Net Cash By Market Cap	$-10.63
Net Debt EBITDA	$1.63
Net Debt Equity	$0.49
Net Debt FCF	$2.46
Tangible Book Value	$-1.3B
Tangible Book Value Per Share	$-3.41
WACC	8.04

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.11
Inventory Turnover	1.7
Net Working Capital	$3.1B
Quick ratio	1.04
Working Capital	$5.3B
Working Capital Turnover	$3.16

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.16%
Dividend Growth	0.28%
Dividend Growth Years	10%
Dividend per share	$2.56
Dividend Years	11
Dividend Yield	0.88%
Ex Div Date	2026-03-31
Last Dividend	$0.67
Payout Frequency	Quarterly
Payout Ratio	38.99%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-23.46%
200-day SMA	362.6
3Y total return	4.61%
50-day SMA	337.1
50-day SMA vs 200-day SMA	50under200
5Y total return	20.55%
All Time High	406.7
All Time High Change	-28.85%
All Time High Date	2025-01-28
All Time Low	127.7
All Time Low Change	126.65%
All Time Low Date	2020-03-23
ATR	13.95
Beta	0.81
Ch YTD	-18.2
High	300
High52	405.8
High52 Date	2025-07-24
High52ch	-28.69%
Low	287.9
Low52	287
Low52 Date	2026-05-08
Low52ch	0.52%
Ma50ch	-14.17%
Price vs 200-day SMA	-20.19%
RSI	26.45
RSI Monthly	37.82
RSI Weekly	30.13
Sharpe ratio	-1.27x
Sortino ratio	-1.4
Total Return	0.73%
Tr YTD	-17.98
Tr1m	-12.97%
Tr1w	-3.49%
Tr3m	-18.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$4.3B
Operating Income Growth	11.38
Operating Income Growth Q	-5.21
Operating Income Growth3 Y	16.16
Operating Income Growth5 Y	14.07
Operating margin	22.54

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	346,813,104%
Net Borrowing	-1,760,433,600
Shares Insiders	9.35%
Shares Institutions	80.12%
Shares Qo Q	0%
Shares Yo Y	0.16%
Short Ratio	2.2

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$3.3B
Average Volume	1,116.35x
Bv Per Share	45.45
CAPEX	$-608.9M
Ch1m	-12.97
Ch1w	-3.49
Ch1y	-24.19
Ch3m	-18.56
Ch3y	1.6
Ch5y	14.48
Ch6m	-18.67
Change	-2.21%
Change From Open	-1.57
Close	295.9
Days Gap	-0.65
Depreciation Amortization	895,620,594
Dollar Volume	100,704.2
Earnings Date	2026-04-30
EBIT	$4.3B
EBITDA	$5.2B
EPS	$6.54
F Score	7
FCF	$3.5B
FCF EV Yield	3.91x
Financing CF	-2,976,965,955
Fiscal Year End	December
Founded	1,941
Graham Number	113.45087
Graham Upside	-60.8
Income Tax	$956.5M
Investing CF	-692,934,075
Is Primary Listing	0
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Lynch Fair Value	$172
Lynch Upside	-40.67
Ma150	355.2
Ma150ch	-18.54%
Ma20	320.7
Ma20ch	-9.76%
Net CF	422,576,190
Open	294
P FCF Ratio	23.18
P OCF Ratio	19.71
Payment Date	2026-04-30
Position In Range	12.45
Ppne	2,851,168,918
Price Date	2026-05-08
Price EBITDA	$15.31
Relative Volume	0.3x
Revenue	19,137,097,350x
SBC By Revenue	0.96x
Share Based Comp	184,025,115
Tax By Revenue	5x
Tax Rate	27.46%
Tr6m	-18.25%
Volume	348

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0R2S dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.9%

$2.56 annual per share

Payout ratio

+39.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+6.8%

10 consecutive years of growth

Total shareholder yield

+0.7%

Next ex-dividend date: 2026-03-31

Performance

LON/0R2S stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0R2S?

Insider, institutional, and short-interest positioning.

Institutional ownership

+80.1%

Share of float held by funds and institutions

Insider ownership

+9.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0R2S momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

26.5

Below 30: short-term oversold

Price vs 200-day MA

-20.2%

50/200-day relationship not available

Beta (5Y)

0.81

Moves roughly with the market

Sharpe ratio

-1.27

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0R2S

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0R2S stock rating?

lon/0R2S is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0R2S analysis?

The full report lives at /stocks/lon/0R2S/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0R2S?

The latest report frames lon/0R2S around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0R2S page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.